Steve Kates

STEVEN A. KATES, Ph.D is a highly experienced pharmaceutical executive with ~ thirty years in R & D for both life science products and human therapeutics and has advanced several compounds through drug development from early pre-clinical to early clinical development. He currently serves as Vice President, Regulatory Affiars at Dicerna Pharmaceuticals and has held senior positions at Takeda, Lakewood-Amedex, Ischemix, Citius Pharmaceuticals, Surface Logix, Consensus and Millipore Corporation. He has been responsible for the successful development of clinical candidates for both 505(b) 2 and NCE applications. Dr. Kates is a world-leading chemist and industry expert in peptide design and manufacture. He has written or co-authored more than 100 articles, reviews, and patents. Dr. Kates has served as editor of Solid-Phase Synthesis: A Practical Guide and ADMET for Medicinal Chemists, A Practical Guide; guest editor of Biopolymers; and as a member of the Editorial Board of International Journal of Peptide Research and Therapeutics. A Visiting Professor of Chemistry at Brandeis University, Dr. Kates earned his B.S. in chemistry from Bates College and his Ph.D. in Synthetic Organic Chemistry from Brandeis University, and conducted post-doctoral studies at The Massachusetts Institute of Technology.